Lincoln Pharmaceuticals Declares 18 Final Dividend Reports Q4 Net Profit of 1163 Crore Rajnath Singh Highlights Strategic Autonomy and Rising Private Sector Role in Indias Defence Sector Diodes Inc CEO Gary Yu Sells 399810 in Stock Insider Transaction Highlights Media Frenzy Over Death of Model Twisha Sharma Highlights Challenges in HighProfile Cases Dow Jones Futures Edge Higher as SP 500 and Nasdaq Reach New Highs AI Stocks Enter Buy Zones Wendy Liu Warns Against AI Dependency Preserving Human Thinking in an Era of Big Techs Privatised Intelligence ASND Q1 2026 Earnings Miss on EPS Amid Ongoing Investment Cycle HTH Q1 2026 Earnings Strong EPS Beat Amid Lower Stock Reaction MG Q1 2026 Earnings EPS Beats Estimates by 553 as Company Reports Profitability Penumbra Q1 2026 Earnings EPS Misses Estimates by 245 Amidst Operational Headwinds Veris Residential Inc Q4 2025 Earnings NarrowerThanExpected Loss Signals Operational Progress SRAD Q1 2026 Earnings EPS Misses Estimates Stock Rises Slightly Inflection Point Acquisition Corp V Units IPEXU Holds Steady at 1099 SPAC Units in Consolidation Mode Coherus Oncology Inc CHRS Rises 255 Key Levels to Watch After Support Hold AudioCodes Ltd AUDC Surges Over 4 as Stock Approaches Key Resistance BranchOut Food Inc BOF Slides 217 Support Test Looms ONE Gas Inc OGS Edges Lower Amid Consolidation Testing NearTerm Support Silicon Valley Turns to Boring Businesses AI and Dealmaking Reshape Unsexy Industries PMTW Q1 2026 Earnings EPS Misses Estimates Amid Challenging Mortgage Market Rave Restaurant Group RAVE Slips 236 as Stock Tests Support Near 275 CNTN Q4 2023 Earnings Significant Loss Beat as Strategic Initiatives Gain Traction ABVC BioPharma Inc Q1 2025 Earnings Narrowed Loss Highlights Continued Pipeline Progress SRTA Q1 2026 Earnings Strong EPS Surprise Signals Turnaround Momentum ASTC Q1 2024 Earnings Loss per Share of 179 Reflects Continued PreRevenue Investment Phase PAC Q1 2026 Earnings Strong EPS Beat Fails to Lift Stock Amid Cautious Sentiment CRISPR Therapeutics Q1 2026 Earnings Slight EPS Miss as Clinical Pipeline Progresses CMCSA Q1 2026 Earnings EPS Beats Estimates Amid Mixed Signals